AGC Biologics, a global therapeutic protein production company, announced yesterday that it has named Christopher Holt as Site Head/General Manager of its Bothell, Washington operations.
Holt will offer leadership and site management overseeing delivery of contract development and manufacturing services.
Holt has more than 20 years of leadership experience in the biotechnology and manufacturing industry, having worked for Lonza, DSM/Patheon and GlaxoSmithKline in the US and Europe.
Marker Therapeutics names new vice president of Regulatory Affairs
Mirati Therapeutics names new vice president, Human Resources
MYM Nutraceuticals names CFO and COO of MYM International Brands
Arch Oncology Names Dennison to Board of Directors
Palladio Biosciences Names Martin Chief Executive Officer
Kronos Bio Expands Scientific Advisory Board with Addition of Roger D. Kornberg, Ph.D.
Vor Biopharma Names Ang as President and Chief Executive Officer
Catabasis Pharmaceuticals Names Cole to its Board of Directors
Altasciences Names Setnik as Chief Scientific Officer
Exicure Names Muralidhar, Hau to its Board of Directors
Seres Therapeutics Names Berenson to its Board of Directors
Ribon Therapeutics Names Parasuraman as Chief Medical Officer, Stewart as Chief Business Officer
Pilatus Comparator Solutions names new Vice President North America